Get Our Top Trade Ideas Delivered Daily - 65% Off Now
get this deal
España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Our Top Trade Ideas Delivered Daily - 65% Off Now
get this deal
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
KINNATE BIOPHARMA INC COM
KNTE
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
15 minutes delayed
Get Report
Comment
KINNATE BIOPHARMA INC COM (KNTE) Forecast
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for KINNATE BIOPHARMA INC COM (NASDAQ:KNTE) Stock
KINNATE BIOPHARMA INC COM Stock (NASDAQ: KNTE)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Tuesday, March 19, 2024
XOMA Corp Entered Into A Merger Agreement To ...
Benzinga Newsdesk
Friday, March 01, 2024
Kinnate Biopharma Inc. Sells Its Investigatio...
Benzinga Newsdesk
Friday, February 16, 2024
Biotech Royalty Aggregator XOMA To Acquire Small Cancer-Drug Developer Kinnate Biopharma
Vandana Singh
Trading Halt: Halt status updated at 8:25:00 ...
Benzinga Newsdesk
XOMA Enters Agreement To Acquire Kinnate Biop...
Benzinga Newsdesk
Wednesday, January 17, 2024
Wedbush Reiterates Neutral on Kinnate Biophar...
Benzinga Newsdesk
Wednesday, November 15, 2023
Why Shapeways Holdings Shares Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Lisa Levin
Kinnate Biopharma shares are trading higher a...
Benzinga Newsdesk
12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga Insights
Why is Cancer-Focused Kinnate Biopharma Stock Trading Higher Today?
Vandana Singh
Kinnate Biopharma Says Letter Indicated Inten...
Benzinga Newsdesk
On Nov 13, Kinnate Biopharma Board Got Letter...
Benzinga Newsdesk
Market-Moving News for November 15th
Benzinga Newsdesk
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga Insights
Foresite Capital Fund In Amended 13D Filing L...
Charles Gross
Thursday, November 09, 2023
Kinnate Biopharma Q3 EPS $(0.65) Beats $(0.67...
Benzinga Newsdesk
Thursday, October 05, 2023
Stocks That Hit 52-Week Lows On Thursday
Benzinga Insights
Tuesday, September 19, 2023
Analysts Move To Sidelines For Cancer Player Kinnate Biopharma After Restructuring
Vandana Singh
Jefferies Maintains Buy on Kinnate Biopharma,...
Benzinga Newsdesk
Benzinga's Top Ratings Upgrades, Downgrades For September 19, 2023
Benzinga Insights
Kinnate Biopharma shares are trading lower af...
Benzinga Newsdesk
Why Is Cancer Firm Kinnate Biopharma Stock Trading Lower Today?
Vandana Singh
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga Insights
Dell Technologies To Rally More Than 15%? Here Are 10 Other Analyst Forecasts For Tuesday
Lisa Levin
Wedbush Downgrades Kinnate Biopharma to Neutr...
Benzinga Newsdesk
HC Wainwright & Co. Downgrades Kinnate Biopha...
Benzinga Newsdesk
Piper Sandler Downgrades Kinnate Biopharma to...
Benzinga Newsdesk
Monday, September 18, 2023
12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga Insights
Kinnate Biopharma Shares Resumed Trading Afte...
Charles Gross
Kinnate Biopharma Inc. Announces Pipeline Upd...
Benzinga Newsdesk
Kinnate Biopharma Shares Halted, News Pending
Benzinga Newsdesk
Thursday, September 07, 2023
Stocks That Hit 52-Week Lows On Thursday
Benzinga Insights
Tuesday, August 15, 2023
HC Wainwright & Co. Reiterates Buy on Kinnate...
Benzinga Newsdesk
Tuesday, August 08, 2023
Kinnate Biopharma Q2 EPS $(0.68) Down From $(...
Benzinga Newsdesk
Thursday, June 08, 2023
10 Analysts Have This to Say About Kinnate Biopharma
Benzinga Insights
The Latest Analyst Ratings for Kinnate Biopharma
Benzinga Insights
HC Wainwright & Co. Reiterates Buy on Kinnate...
Benzinga Newsdesk
Thursday, May 18, 2023
Kinnate Biopharma in Focus: Analyst's Adjusted Price Target and the Potential of KIN-3248
Vandana Singh
Expert Ratings for Kinnate Biopharma
Benzinga Insights
HC Wainwright & Co. Maintains Buy on Kinnate ...
Benzinga Newsdesk
Friday, May 12, 2023
Wedbush Reiterates Outperform on Kinnate Biop...
Benzinga Newsdesk
Stifel Maintains Hold on Kinnate Biopharma, R...
Benzinga Newsdesk
Wednesday, May 03, 2023
Trilogy Metals And 2 Other Penny Stocks Insiders Are Aggressively Buying
Lisa Levin
Wednesday, April 26, 2023
Stocks That Hit 52-Week Lows On Wednesday
Benzinga Insights
Monday, April 24, 2023
Stocks That Hit 52-Week Lows On Monday
Benzinga Insights
Friday, April 21, 2023
Stocks That Hit 52-Week Lows On Friday
Benzinga Insights
Thursday, April 20, 2023
Stocks That Hit 52-Week Lows On Thursday
Benzinga Insights
Wednesday, April 19, 2023
Goldman Sachs Maintains Buy on Kinnate Biopha...
Benzinga Newsdesk
Tuesday, April 18, 2023
What 4 Analyst Ratings Have To Say About Kinnate Biopharma
Benzinga Insights
Goldman Sachs Maintains Buy on Kinnate Biopha...
Benzinga Newsdesk
Show More